{"name":"ChemomAb Ltd.","slug":"chemomab-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQbGtNdnEtaFlyM0xZa2ZVa25kd1BEWDZFSnJiMG9LR3JlZWJZUWVfZm5pQVMzM1MwSUc3NVlMaG5YaGR4dDZkOHRNWmRGclpRQ193RFozZlUyVldFZ2twZUJZOUE3Tl8xQU94MFFzV25NbDY0U3ZRNS01QWE1dmhreUt1YlhZMEtVc3ZEeWJiSTVxdWtNM1B1UU9Lcw?oc=5","date":"2026-04-07","type":"pipeline","source":"openPR.com","summary":"Primary Sclerosing Cholangitis Market is expected to Hit US$ - openPR.com","headline":"Primary Sclerosing Cholangitis Market is expected to Hit US$","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNYzl2TlNpd1QyTWdBNGgzYkN4a21aa29TTDhGZjNUM0ZXNWViT3k4TzJ2VWtjZEVJcTNLcmsxV1hsWnJPaTNVM3dKem1WZnNId3JNZXlmSlZqSGRZY0JqdWlMYkV4SWlKMGtLTzZOWU04QzRaRmFNeDVickNDUkdHVHdGODVsS25UWGJuZDhJeW9Xc25KNmllX3J2eFloUUUwYnh5LTEtU2VrdUoyakFtdDVSVU9aNE8tUlBwNFNqbExTZF9JeVAxT1ZaNA?oc=5","date":"2026-03-31","type":"pipeline","source":"Stock Titan","summary":"Chemomab Therapeutics (CMMB) director lists vested stock option grants - Stock Titan","headline":"Chemomab Therapeutics (CMMB) director lists vested stock option grants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOQXpfaHh4ZTd2LVEyVXVTcXVfc3JkZ2V0T3ljd2dPdzFWY28tMW5JcnhUMDgxMk5uOUZBWFFRRUJ1WGNtdl9QOUY3aHJhMkJqams5NW1hbkhYRVpqTnU1SmlFZW50OFU5SlRQZ2JXYkJaMkU0RDJWY25jdUpmOGpiX0RxckY1WXNWRXNQOVlPdWZJMFpwem8zZGp5Q0thazFGbjI4ak80Sm1CYWtrQUxpb2tDcllZem45OS0zdW5nejd3TDl1RkxoRFJsdw?oc=5","date":"2026-03-31","type":"pipeline","source":"Stock Titan","summary":"Chemomab (CMMB) director Claude Nicaise lists six vested option grants - Stock Titan","headline":"Chemomab (CMMB) director Claude Nicaise lists six vested option grants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOYWZzWW1VMXZrWFFVWjRueDRwRVktamxsWXItWHl5ZWs2TExlNktfWjRDUTAxUGdQVFVNSExSLWEtUGRwVC05S0ZsUzhVbS1ubWswSzZnYllHSjM2dFJXWWRzVzdZOW1RRm1xY0pLMTAyYlRhdGhHNURMWWdydW1xZkVNN3R3U19NbmtRdm51SVM4aENzR0hTazlMRGJ3ODUtaU1DVFpBVjZGTno5UmUxcA?oc=5","date":"2026-03-19","type":"earnings","source":"Yahoo Finance","summary":"Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update - Yahoo Finance","headline":"Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNcTItdVRyQmhiTHY5R3ByNHdvTWZteWNoZHA4U0doQUJQQnNabEpQV0hUTHVGTkw2Y0thaU9YMnc0MXFtSDlMLUc1T1hSc3ZqZDB1Q1Rxd3JfYmtLSTZ0bW43Y1lKenNGbXlPaGNYZTVHYUdjSlNXdDY3NURvWG9jREItTjlCeXd4ekFtZzRkQTlYdXhRenQxOWhpeUFrYTl1bm5GMDFNT01zb0NSOEFIcnJHOFpnMmZEUlFXY21B?oc=5","date":"2026-03-19","type":"regulatory","source":"Stock Titan","summary":"Chemomab (Nasdaq: CMMB) cuts 2025 loss and aligns with FDA on PSC Phase 3 - Stock Titan","headline":"Chemomab (Nasdaq: CMMB) cuts 2025 loss and aligns with FDA on PSC Phase 3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxQalllVUpOLXlHektrRVV6Q1R1VlBNaGlrc3VHSlRjcF91UkgyOHFmZGNMX0dvM1JhUkR1a0hTODVfNm13cUZtZjNBT1BJY191dzRCVmRKMjJzWTBjU2dOczhRM0lnalFhSndYWlV1V2lVQS05X2tLVVRvMWNkYkZvMGs2eERDa0dVV08xeUZfWUFYTXF1QnQ5Vl84SjE2WUpjUmtJU1ItZmFuTFg0UnhqZXpRbTA0QXFYcHctYmRZOXdKVkRZX1FJY2ZNcm8waFNHV1N4MGtsNjlXQkVTeW1pRDdhTklmUFlnemFtSjV6M3ZPSkc3aDdrb2Y0T3gzVHNJMXVLU3o1eDk4eTd3cUhlUmx2Y2pZMjVYUkFNci1EU2JJQm5Jd3Y3cUxFWVpMXzJHY1VvTXNCclVZZw?oc=5","date":"2026-02-05","type":"regulatory","source":"PR Newswire","summary":"Primary Sclerosing Cholangitis Market Outlook Highlights Rising Demand and Expanding Treatment Landscape Throughout the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"Primary Sclerosing Cholangitis Market Outlook Highlights Rising Demand and Expanding Treatment Landscape Throughout the ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1Va3JBYzBRazBkaHlaYk5tZmNING4wVzYtV0g4UktURmhlNXBCelNpNkRhbTRQWkkydXZJSUJ2X2Y2WUYwUndGeXVJWEYyV3dxcW9wLXVyUzRfcmNuTmhGbVI0cDBkb2w3M1h2OXRPTmk?oc=5","date":"2024-12-23","type":"pipeline","source":"Built In","summary":"20 Pharmaceutical Companies in Israel to Know - Built In","headline":"20 Pharmaceutical Companies in Israel to Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFB4WU16a1lqRDhBT2RLclJ3RHU3REt5NmVLazlXRU1sQ0RDM2xUQmxMaXZyMHUzZG1vcTNGZkFXbFpwbGVNWENlUzhMbEJ4Um9VVGc?oc=5","date":"2021-06-30","type":"pipeline","source":"au.finance.yahoo.com","summary":"Chemomab Therapeutics Ltd. (CMMB) stock price, news, quote and history - au.finance.yahoo.com","headline":"Chemomab Therapeutics Ltd. (CMMB) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNdE1kVVpxeUlxS3NNVDhKTkVXR3dmb0V4eG1QV2Nud3RyaFV3UlBCVXBVT2hfWjF4SktScEViM3U5UmtFOFJrcVdVdGYzVEZCMk1IbkZzc2c5NUgyUG1oX0ZFLVVEUmw4ajRXdTBibjRKYmNZYWU2Z2ktdjNmbTZfaVhhTmRXR2QxTV9ZQXBYR0lYRVpxYVhycVd2S2Z4LVpKckJBYmNhTFgyU0Jo?oc=5","date":"2021-03-16","type":"deal","source":"PR Newswire","summary":"Chemomab Completes Merger with Anchiano Therapeutics - PR Newswire","headline":"Chemomab Completes Merger with Anchiano Therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}